BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Tuesday reported a loss of $39 million in its first quarter.
On a per-share basis, the Berkeley, California-based company said it had a loss of 63 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
The biopharmaceutical company posted revenue of $165,000 in the period.
Dynavax Technologies shares have decreased 11 percent since the beginning of the year. The stock has more than tripled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX at https://www.zacks.com/ap/DVAX